Related Experiment Videos
[Experimento-clinical basis for using papain in purulent surgery]
Vestnik Khirurgii Imeni I. I. Grekova
|June 1, 1984
Summary
Papain, a plant-derived enzyme, demonstrated no toxicity in experimental injections. Clinical application in wound treatment showed high proteolytic activity, accelerating healing without complications, making it suitable for purulent surgery.
Area of Science:
- Biochemistry
- Wound Healing
- Surgical Practice
Background:
- Purulent processes pose significant challenges in wound healing.
- Effective proteolytic enzymes are needed for wound management.
- Papain is a proteolytic enzyme derived from plants.
Purpose of the Study:
- To evaluate the safety and efficacy of papain in treating purulent processes.
- To assess the proteolytic activity and wound healing effects of papain.
- To determine the suitability of papain for surgical applications.
Main Methods:
- Experimental injections of papain (5-36 mg/kg) to assess toxicity.
- Clinical use of 0.2-0.5% papain solution for local treatment of purulent wounds.
- Observation of wound healing phases and complication monitoring.
Main Results:
- Papain injections showed no toxic effects on the body or serous membranes.
- Clinical use demonstrated high proteolytic activity.
- Papain application shortened the initial phase of wound healing.
- No local or general complications were observed.
Conclusions:
- Papain is a safe and effective proteolytic agent for wound treatment.
- Papain accelerates the healing of purulent processes.
- Papain is a viable option for purulent surgery in various healthcare settings.